tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VERA Stock Latest News

Vera Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research
The FlyVera Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research
12h ago
VERA
VRTX
Vertex poses ‘no threat’ to Vera Therapeutics’ atacicept, says BofA
PremiumThe Fly
Vertex poses ‘no threat’ to Vera Therapeutics’ atacicept, says BofA
23h ago
VERA
VRTX
Maintaining the Bull Case on Vera: Atacicept’s Competitive Edge and $2.2B IgAN Peak Sales Upside
PremiumRatings
Maintaining the Bull Case on Vera: Atacicept’s Competitive Edge and $2.2B IgAN Peak Sales Upside
24h ago
VERA
Vera Therapeutics Adds Christopher Hite to Board
PremiumCompany Announcements
Vera Therapeutics Adds Christopher Hite to Board
2d ago
8K
VERA
Vera Therapeutics appoints Hite to Board of Directors
PremiumThe Fly
Vera Therapeutics appoints Hite to Board of Directors
6d ago
VERA
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
PremiumMarket News3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
8d ago
UPB
VERA
Vera Therapeutics price target raised to $110 from $90 at H.C. Wainwright
Premium
The Fly
Vera Therapeutics price target raised to $110 from $90 at H.C. Wainwright
9d ago
VERA
Vera Therapeutics: Strong Atacicept Phase 3 Data and Favorable Regulatory, Commercial Setup Support Buy Rating
Premium
Ratings
Vera Therapeutics: Strong Atacicept Phase 3 Data and Favorable Regulatory, Commercial Setup Support Buy Rating
12d ago
VERA
Undervalued IgAN Opportunity: Buy Rating on VERA Driven by Atacicept’s Robust ORIGIN 3 Data and Long-Term Kidney Disease Upside
PremiumRatings
Undervalued IgAN Opportunity: Buy Rating on VERA Driven by Atacicept’s Robust ORIGIN 3 Data and Long-Term Kidney Disease Upside
12d ago
VERA
Vera Therapeutics: Buy Rating Backed by Strong Atacicept Data, Robust Cash Runway, and Large IgAN Market Opportunity
PremiumRatings
Vera Therapeutics: Buy Rating Backed by Strong Atacicept Data, Robust Cash Runway, and Large IgAN Market Opportunity
13d ago
VERA
Vera Therapeutics reports FY25 EPS ($4.66), consensus ($4.44)
PremiumThe Fly
Vera Therapeutics reports FY25 EPS ($4.66), consensus ($4.44)
13d ago
VERA
Vera Therapeutics sees cash runway through atacicept commercial launch
PremiumThe Fly
Vera Therapeutics sees cash runway through atacicept commercial launch
13d ago
VERA
Vera Therapeutics appoints Skelton as Chief Commercial Officer
PremiumThe FlyVera Therapeutics appoints Skelton as Chief Commercial Officer
1M ago
VERA
Buy Rating on Vera: De-Risked Atacicept Approval Path and Large IgA Nephropathy Market Drive Compelling Upside into 2026 Catalysts
Premium
Ratings
Buy Rating on Vera: De-Risked Atacicept Approval Path and Large IgA Nephropathy Market Drive Compelling Upside into 2026 Catalysts
2M ago
VERA
Vera Therapeutics announces atacicept BLA accepted for Priority Review by FDA
Premium
The Fly
Vera Therapeutics announces atacicept BLA accepted for Priority Review by FDA
2M ago
VERA
Wolfe upgrades Vertex Pharmaceuticals, says ‘may be due for a rebound’
PremiumThe Fly
Wolfe upgrades Vertex Pharmaceuticals, says ‘may be due for a rebound’
2M ago
VERA
VRTX
Short Report: Vera Therapeutics bears retreat as stock rallies
PremiumThe Fly
Short Report: Vera Therapeutics bears retreat as stock rallies
3M ago
MBLY
MDGL
Vera Therapeutics price target raised to $66 from $48 at BofA
PremiumThe Fly
Vera Therapeutics price target raised to $66 from $48 at BofA
3M ago
VERA
Vera Therapeutics price target raised to $95 from $55 at Goldman Sachs
PremiumThe Fly
Vera Therapeutics price target raised to $95 from $55 at Goldman Sachs
3M ago
VERA
Vera Therapeutics price target lowered to $96 from $99 at JPMorgan
PremiumThe FlyVera Therapeutics price target lowered to $96 from $99 at JPMorgan
3M ago
VERA
Vera Therapeutics: Reinforced Buy on Atacicept’s Leading IgAN Profile, Robust Cash Runway, and Expanded Peak Sales Potential
Premium
Ratings
Vera Therapeutics: Reinforced Buy on Atacicept’s Leading IgAN Profile, Robust Cash Runway, and Expanded Peak Sales Potential
3M ago
VERA
Vera Therapeutics Announces Departure of Chief Legal Officer
Premium
Company Announcements
Vera Therapeutics Announces Departure of Chief Legal Officer
3M ago
8K
VERA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >